Lack of effect of β-cyclodextrin and its water-soluble derivatives on in vitro drug transport across rat intestinal epithelium

International Journal of Pharmaceutics

Volumn 309, Issue 1-2, 2006, Pages 123-128

  Zheng, Ying ^a   Zuo, Zhong ^a   L Chow, Albert H ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cyclodextrins; Drug transport; Intestinal permeability; Ussing Chamber

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; BETA CYCLODEXTRIN SULFOBUTYL ETHER; LUCIFER YELLOW; PROPRANOLOL;

ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ILEUM; IN VITRO STUDY; INTESTINE EPITHELIUM; MALE; NONHUMAN; OSMOLARITY; PERMEABILITY; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; RAT; SOLUBILITY; SPECTROFLUOROMETRY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BETA-CYCLODEXTRINS; DIFFUSION CHAMBERS, CULTURE; DRUG CARRIERS; FLUORESCENT DYES; ILEUM; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; ISOQUINOLINES; MALE; OSMOLAR CONCENTRATION; PERMEABILITY; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; WATER;

EID: 31144435904     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.11.022     Document Type: Article

References (23)

1. Anderberg, E.K., Artursson, P., 1993. Cell cultures to assess drug absorption enhancement. In: A. (Bert) G de Boer (Ed.) Drug Absorption Enhancement: Concepts, Possibilities, Limitations and Trends, vol. 3, Harwood Academic Publishers, pp. 101-118.
2. P. Artursson Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J. Pharm. Sci. 79 1990 476 482
3. K. Asai, M. Morishita, H. Katsuta, S. Hosoda, K. Shinomiya, M. Noro, T. Nagai, and K. Takayama The effect of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa Int. J. Pharm. 246 2002 25 35
4. Y.B. Chung, K. Han, A. Nishiura, and V.H. Lee Ocular absorption of Pz-peptide and its effect on the ocular and systemic pharmacokinetics of topically applied drugs in the rabbit Pharm. Res. 15 1998 1882 1887
5. M.E. Dowty, and C.R. Dietsch Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability Pharm. Res. 14 1997 1792 1797
6. B. Haeberlin, T. Gengenbacher, A. Meinzer, and G. Fricker Cyclodextrins - useful excipients for oral peptide administration? Int. J. Pharm. 137 1996 103 110
7. L. Hovgaard, and H. Brønsted Drug delivery studies in Caco-2 monolayers. I.V. Absorption enhancer effects of cyclodextrins Pharm. Res. 12 1995 1328 1332
8. P. Krugliak, D. Hollander, C.C. Schlaepfer, H. Nguyen, and T.Y. Ma Mechanisms and sites of mannitol permeability of small and large intestine in the rat Dig. Dis. Sci. 39 1994 796 801
9. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1996 1017 1025
10. I. Miyazawa, H. Ueda, H. Nagase, T. Endo, S. Kobayshi, and T. Nagai Physicochemical properties and inclusion complex formation of γ-cylcodextrin Eur. J. Pharm. Sci. 3 1995 153 162
11. K. Nakanishi, T. Nadai, M. Masada, and K. Miyajima Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins Chem. Pharm. Bull. 40 1992 1252 1256
12. N. Ono, H. Arima, F. Hirayama, and K. Uekama A moderate interaction of maltosyl-α-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin Biol. Pharm. Bull. 24 2001 395 402
13. C. Pak, P.J. Marriot, P.D. Carpenter, and R.G. Amiet Enantiomeric separation of propranolol and selected metabolites by using capillary electrophoresis with hydroxypropyl-beta-cyclodextrin as chiral selector J. Chromatogr. A. 793 1998 357 364
14. M. Plätzer, M.A. Schwarz, and R.H.H. Neubert Determination of formation constants of cyclodextrin inclusion complexes using affinity capillary electrophoresis J. Microcolumn Separations 11 1999 215 222
15. B.I. Polentarutti, A.L. Peterson, K. Sjöberg, E.K.I. Anderberg, L.M. Utter, and A.L.B. Ungell Evaluation of viability of excised rat intestinal segments in the Ussing Chamber: investigation of morphology, electrical parameters, and permeability characteristics Pharm. Res. 16 1999 446 454
16. R.A. Rajewski, and V.J. Stella Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery J. Pharm. Sci. 85 1996 1142 1169
17. D.S. Shaker, A.H. Ghanem, S.K. Li, K.S. Warner, F.M. Hashem, and W.I. Higuchi Mechanistic studies of the effect of hydroxypropyl-β-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin Int. J. Pharm. 253 2003 1 11
18. Z. Shao, Y. Li, T. Chermak, and A.K. Mitra Cyclodextrins as mucosal absorption promoters of insulin. II. Effects of β-cyclodextrin derivatives on α-chymotryptic degradation and enteral absorption on insulin in rats Pharm. Res. 11 1994 1174 1179
19. W.C. Shen, and Y.J. Lin Basic mechanisms in transepithelium transport enhancement D.S. Hsieh Drug Permeation Enhancement: Theory and Applications vol. 3 1994 Marcel Dekker, Inc. 25 40
20. V.J. Stella, and R.A. Rajewski Cyclodextrins: their future in drug formulation and delivery Pharm. Res. 14 1997 556 567
21. A.M. Tötterman, N.G.M. Schipper, D.O. Thompson, and J.P. Mannermaa Intestinal safety of water-soluble β-cyclodextrins in paediatric oral solutions of spironolactone: effects on human intestinal epithelial Caco-2 cells J. Pharm. Pharmacol. 49 1997 43 48
22. K. Uekama, F. Hirayama, and T. Irie Cyclodextrin drug carrier systems Chem. Rev. 98 1998 2045 2076
23. G. Xie, D.J. Skanchy, and J.F. Stobaugh Chiral separations of enantiomeric pharmaceuticals by capillary electrophoresis using sulphobutyl ether β-cyclodextrin as isomer selector Biomed. Chromatogr. 11 1997 193 199